Johnson & Johnson (JNJ) Reports a Beat-and-Raise 3Q, Analyst Positive
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Johnson & Johnson (JNJ) Tops Q3 EPS by 24c, Raises FY Guidance
October 19, 2021 6:27 AM EDT(Updated - October 19, 2021 6:28 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.60, $0.24 better than the analyst estimate of $2.36. Revenue for the quarter came in at $23.3 billion versus the consensus estimate of $23.74 billion.
GUIDANCE:
Johnson & Johnson sees 2021 EPS of $9.77-$9.82,... More
